MLKL and neoplasm: In a similar strategy, the direct intratumoral delivery of mRNA coding for the necroptosis executioner MLKL, followed by in vivo electroporation at the injection site, reduced tumor growth and metastasis, synergized with immune checkpoint blockade, and improved antitumor immunity in murine melanoma and colon carcinoma models (62).